Targeting stearoyl-CoA desaturase 1 to repress endometrial cancer progression

Weihua Li1,2, Huimin Bai2, Shiping Liu3

  • 1Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Wangfujing, Beijing 100730, China.

Oncotarget
|March 20, 2018
PubMed

Insights

Stearoyl-CoA desaturase 1 (SCD1) is highly expressed in endometrial cancer. Inhibiting SCD1 repressed cancer cell growth and impaired tumor progression, indicating its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Stearoyl-CoA desaturase 1 (SCD1) is a key enzyme in lipid metabolism and a known target in various cancers.
  • The role of SCD1 in endometrial cancer progression remains largely unexplored.

Purpose of the Study:

  • To investigate the expression and functional significance of SCD1 in human endometrial cancer.
  • To evaluate SCD1 as a potential therapeutic target for endometrial cancer treatment.

Main Methods:

  • SCD1 expression analysis in normal endometrium, hyperplasia, and endometrial carcinoma tissues.
  • In vitro studies using short hairpin RNA (shRNA) and chemical inhibitors to knockdown SCD1 in endometrial cancer cell lines.
  • In vivo xenograft models to assess the effect of SCD1 inhibition on tumor growth.

Main Results:

  • SCD1 was highly expressed in endometrial hyperplasia and carcinoma compared to normal endometrium.
  • SCD1 knockdown significantly inhibited endometrial cancer cell proliferation and induced apoptosis.
  • Inhibition of SCD1 suppressed foci formation in a metastatic endometrial cell line and impaired tumor growth in vivo.

Conclusions:

  • SCD1 is upregulated in endometrial cancer and plays a crucial role in cancer cell growth and progression.
  • Targeting SCD1 represents a promising therapeutic strategy for endometrial cancer by disrupting lipid metabolism.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Repressed Memory01:16

Repressed Memory

Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...
529
Repressible Operon: trp Operon01:21

Repressible Operon: trp Operon

The trp operon in Escherichia coli exemplifies a repressible operon. It regulates the synthesis of tryptophan through repressor-mediated transcriptional control and attenuation. This dual regulatory mechanism ensures tryptophan biosynthesis occurs only when needed, conserving cellular resources.Structure of the trp OperonThe trp operon consists of five structural genes (trpE, trpD, trpC, trpB, and trpA) that encode enzymes for tryptophan biosynthesis. These genes are transcribed as a single...
1.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
SN1 Reaction: Stereochemistry02:15

SN1 Reaction: Stereochemistry

This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.4K